Trial reportCurrent oncology (Toronto, Ont.)2025
Using Invitation Letters to Increase HPV Vaccination Among Adult Women.
Trial report in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
(1) Background: In Manitoba, most people get the HPV vaccine through a publicly funded school-based program. If they miss the school-based program, they remain eligible for the free HPV immunization program. This study explored whether invitation and reminder letters would increase HPV vaccine uptake among adult women who remained eligible for the publicly funded program. (2) Methods: Eligible individuals were randomized into three groups of 4650 women each. Intervention groups I and II were mailed an information package inviting them to be vaccinated. Six weeks later, intervention group II received a reminder letter if they remained unvaccinated. The control group received no correspondence related to HPV vaccination. Vaccination status, defined as at least one dose of an approved HPV vaccine, was calculated six months after the packages were mailed. (3) Results: Overall, 4.0% (3.4-4.6%,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.